World Health Organization Adopts Historic Pandemic Agreement to Enhance Global Response to Future Pandemics

Strategic Insights -

The world is now safer thanks to the adoption of the WHO Pandemic Agreement, a landmark decision by the 78th World Health Assembly that marks the culmination of over three years of intensive negotiations initiated by governments in response to the COVID-19 pandemic. The agreement aims to strengthen global collaboration and ensure a more equitable response to future pandemics. The next steps include negotiations on the Pathogen Access and Benefits Sharing system, which will be considered at next year's World Health Assembly.

Key Takeaways:

  • The WHO Pandemic Agreement was adopted by consensus by the 78th World Health Assembly, marking a significant milestone in global cooperation to combat pandemics.
  • The agreement sets out the principles, approaches, and tools for better international coordination across various areas, including equitable and timely access to vaccines, therapeutics, and diagnostics.
  • The agreement acknowledges national sovereignty, stating that nothing in the agreement shall be interpreted as providing the WHO with authority to direct or alter national laws or policies.
  • Pharmaceutical manufacturers participating in the Pathogen Access and Benefits Sharing system will make available 20% of their real-time production of safe, quality, and effective vaccines, therapeutics, and diagnostics for the pathogen causing the pandemic emergency.
  • The distribution of these products will be carried out on the basis of public health risk and need, with particular attention to the needs of developing countries.
  • The WHO Pandemic Agreement entered into force once 60 ratifications are achieved, marking a significant step towards enhancing global response to future pandemics.
  • The agreement also launched a process to draft and negotiate a Pathogen Access and Benefits Sharing system through an Intergovernmental Working Group.

Statistics:

  • 124 Member States voted in favor of the WHO Pandemic Agreement, with 0 objections and 11 abstentions.
  • 20% of real-time production of vaccine, therapeutics, and diagnostics will be made available by pharmaceutical manufacturers for the pathogen causing the pandemic emergency.
  • 60 ratifications are required for the WHO Pandemic Agreement to enter into force.
  • 11 countries abstained from voting on the WHO Pandemic Agreement.
  • 124 countries voted in favor of the agreement in Committee by Member State delegations.

Sources:

  • World Health Organization.
  • World Health Assembly.
  • Dr. Tedros Adhanom Ghebreyesus, WHO Director-General.
  • Dr. Teodoro Herbosa, Secretary of the Philippines Department of Health, and President of this year's World Health Assembly.